Top

Published in:

01-10-2014 | Original Paper

Lipopolysaccharide-binding protein: A valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?

Authors: Max J. Friedrich, Thomas M. Randau, Matthias D. Wimmer, Ben Reichert, Dominik Kuberra, Birgit Stoffel-Wagner, Dieter C. Wirtz, Sascha Gravius

Published in: International Orthopaedics | Issue 10/2014

Abstract

Purpose

The pre-operative differentiation between periprosthetic joint infection (PJI) and aseptic loosening after total hip (THA) or knee (TKA) arthroplasty is essential for successful therapy and relies in part on the use of molecular markers. The objective of this study was to assess serum levels of lipopolysaccharide-binding protein (LBP) as a diagnostic tool for PJI and to compare its accuracy with standard tests.

Methods

One hundred and twenty patients presenting with a painful TKA or TKA with indication for surgical revision were included in this prospective, controlled, clinical trial at a single centre. Pre-operative blood and serum samples were collected and analysed for white blood cell (WBC) count, C-reactive protein (CRP) and LBP. The definite diagnosis of periprosthetic joint infection was determined on the basis of clinical, microbiological and histopathological examination.

Results

LBP showed significantly higher values in PJI compared with aseptic loosening (p < 0.001) and control (p < 0.001), with a specificity of 66 % and a sensitivity of 71 % at a cutoff value of >7 ng/ml. In combination with CRP, the positive predictive value for PJI was at 0.67; negative predictive value with both negative was at 0.77.

Discussion

Patients with PJI have elevated serum levels of LBP when compared with patients with aseptic loosening. The use of LBP in serum appears not to be a more accurate marker than CRP level in serum for detecting PJI. On the basis of these results, we cannot recommend the sole use of LBP for differentiating PJI and aseptic loosening following THA and TKA.

Trampuz A, Zimmerli W (2005) New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs 6:185–190PubMed

Frommelt L (2004) Guidelines on antimicrobial therapy in situations of periprosthetic THR infection. Orthopade 33:822–828. doi:10.1007/s00132-004-0677-5 PubMedCrossRef

Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645–1654. doi:10.1056/NEJMra040181 PubMedCrossRef

Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am Vol 92:2102–2109. doi:10.2106/JBJS.I.01199 CrossRef

Deirmengian C, Hallab N, Tarabishy A, Della Valle C, Jacobs JJ, Lonner J, Booth RE Jr (2010) Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res 468:2017–2023. doi:10.1007/s11999-010-1298-4 PubMedCrossRefPubMedCentral

Gollwitzer H, Dombrowski Y, Prodinger PM, Peric M, Summer B, Hapfelmeier A, Saldamli B, Pankow F, von Eisenhart-Rothe R, Imhoff AB, Schauber J, Thomas P, Burgkart R, Banke IJ (2013) Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. J Bone Joint Surg Am Vol 95:644–651. doi:10.2106/JBJS.L.00205 CrossRef

Glehr M, Friesenbichler J, Hofmann G, Bernhardt GA, Zacherl M, Avian A, Windhager R, Leithner A (2013) Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res 471:2621–2628. doi:10.1007/s11999-013-2998-3 PubMedCrossRefPubMedCentral

Hundric-Haspl Z, Pecina M, Haspl M, Tomicic M, Jukic I (2006) Plasma cytokines as markers of aseptic prosthesis loosening. Clin Orthop Relat Res 453:299–304. doi:10.1097/01.blo.0000229365.57985.96 PubMedCrossRef

Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG (2011) New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 469:2992–2994. doi:10.1007/s11999-011-2102-9 PubMedCrossRefPubMedCentral

10.

Gollwitzer H, Diehl P, Gerdesmeyer L, Mittelmeier W (2006) Diagnostic strategies in cases of suspected periprosthetic infection of the knee. A review of the literature and current recommendations. Orthopade 35:904. doi:10.1007/s00132-006-0977-z, 906–908, 910–906PubMedCrossRef

11.

Ghanem E, Antoci V Jr, Pulido L, Joshi A, Hozack W, Parvizi J (2009) The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis 13:e444–e449. doi:10.1016/j.ijid.2009.02.017 PubMedCrossRef

12.

Parvizi J, Ghanem E, Menashe S, Barrack RL, Bauer TW (2006) Periprosthetic infection: what are the diagnostic challenges? J Bone Joint Surg Am Vol 88(Suppl 4):138–147. doi:10.2106/JBJS.F.00609 CrossRef

13.

Toossi N, Adeli B, Rasouli MR, Huang R, Parvizi J (2012) Serum white blood cell count and differential do not have a role in the diagnosis of periprosthetic joint infection. J Arthroplast 27:51–54 e51. doi:10.1016/j.arth.2012.03.021 CrossRef

14.

Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR (1998) Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol 36:2932–2939PubMedPubMedCentral

15.

Kobayashi N, Inaba Y, Choe H, Iwamoto N, Ishida T, Yukizawa Y, Aoki C, Ike H, Saito T (2009) Rapid and sensitive detection of methicillin-resistant Staphylococcus periprosthetic infections using real-time polymerase chain reaction. Diagn Microbiol Infect Dis 64:172–176. doi:10.1016/j.diagmicrobio.2009.01.033 PubMedCrossRef

16.

Morawietz L, Classen RA, Schroder JH, Dynybil C, Perka C, Skwara A, Neidel J, Gehrke T, Frommelt L, Hansen T, Otto M, Barden B, Aigner T, Stiehl P, Schubert T, Meyer-Scholten C, Konig A, Strobel P, Rader CP, Kirschner S, Lintner F, Ruther W, Bos I, Hendrich C, Kriegsmann J, Krenn V (2006) Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol 59:591–597. doi:10.1136/jcp.2005.027458 PubMedCrossRefPubMedCentral

17.

Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R (2004) Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 117:556–562. doi:10.1016/j.amjmed.2004.06.022 PubMedCrossRef

18.

Weiss S, Geiss H, Kommerell M, Simank HG, Bernd L, Henle P (2006) Improving the diagnosis of septic arthritis by use of a pediatric blood culture system. Orthopade 35:456. doi:10.1007/s00132-005-0900-z, 458–462PubMedCrossRef

19.

Randau T, Friedrich M, Wimmer M, Reichert B, Kuberra D, Stoffel-Wagner B, Limmern A, Wirtz D, Gravius S (2014) IL-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening. PloS One Under Review

20.

Janz V, Wassilew GI, Hasart O, Matziolis G, Tohtz S, Perka C (2013) Evaluation of sonicate fluid cultures in comparison to histological analysis of the periprosthetic membrane for detecting periprosthetic joint infection. Int Orthop 37:931–936. doi:10.1007/s00264-013-1853-1 PubMedCrossRefPubMedCentral

21.

Zweigner J, Schumann RR, Weber JR (2006) The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect/Institut Pasteur 8:946–952. doi:10.1016/j.micinf.2005.10.006 CrossRef

22.

Geller DA, Kispert PH, Su GL, Wang SC, Di Silvio M, Tweardy DJ, Billiar TR, Simmons RL (1993) Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response. Arch Surg 128:22–27, discussion 27–28PubMedCrossRef

23.

Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F (1996) The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 16:3490–3503PubMedPubMedCentral

24.

Hallatschek W, Fiedler G, Kirschning CJ, Creutzburg F, Lamping N, Nussler A, Schumann RR (2004) Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor beta 1. Eur J Immunol 34:1441–1450. doi:10.1002/eji.200324874 PubMedCrossRef

25.

Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR (2001) High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98:3800–3808PubMedCrossRef

26.

Wimmer MD, Randau TM, Petersdorf S, Pagenstert GI, Weisskopf M, Wirtz DC, Gravius S (2013) Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections. Int Orthop 37:2271–2278. doi:10.1007/s00264-013-1995-1 PubMedCrossRef

27.

Laffer RR, Graber P, Ochsner PE, Zimmerli W (2006) Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect : Off Publ Eur Soc Clin Microbiol Infect Dis 12:433–439. doi:10.1111/j.1469-0691.2006.01378.x CrossRef

28.

Krenn V, Morawietz L, Kienapfel H, Ascherl R, Matziolis G, Hassenpflug J, Thomsen M, Thomas P, Huber M, Schuh C, Kendoff D, Baumhoer D, Krukemeyer MG, Perino G, Zustin J, Berger I, Ruther W, Poremba C, Gehrke T (2013) Revised consensus classification. Histopathological classification of diseases associated with joint endoprostheses. Z Rheumatol 72:383–392. doi:10.1007/s00393-012-1099-0 PubMedCrossRef

29.

Bozic KJ, Rubash HE (2004) The painful total hip replacement. Clin Orthop Relat Res 420:18–25PubMedCrossRef

30.

Bernard L, Lubbeke A, Stern R, Bru JP, Feron JM, Peyramond D, Denormandie P, Arvieux C, Chirouze C, Perronne C, Hoffmeyer P, Groupe D’Etude Sur LO (2004) Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand J Infect Dis 36:410–416PubMedCrossRef

31.

Alijanipour P, Bakhshi H, Parvizi J (2013) Diagnosis of periprosthetic joint infection: the threshold for serological markers. Clin Orthop Relat Res 471:3186–3195. doi:10.1007/s11999-013-3070-z PubMedCrossRef

32.

Buttaro MA, Tanoira I, Comba F, Piccaluga F (2010) Combining C-reactive protein and interleukin-6 may be useful to detect periprosthetic hip infection. Clin Orthop Relat Res 468:3263–3267. doi:10.1007/s11999-010-1451-0 PubMedCrossRefPubMedCentral

33.

Parvizi J, McKenzie JC, Cashman JP (2012) Diagnosis of periprosthetic joint infection using synovial C-reactive protein. J Arthroplast 27:12–16. doi:10.1016/j.arth.2012.03.018 CrossRef

34.

Piper KE, Fernandez-Sampedro M, Steckelberg KE, Mandrekar JN, Karau MJ, Steckelberg JM, Berbari EF, Osmon DR, Hanssen AD, Lewallen DG, Cofield RH, Sperling JW, Sanchez-Sotelo J, Huddleston PM, Dekutoski MB, Yaszemski M, Currier B, Patel R (2010) C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One 5:e9358. doi:10.1371/journal.pone.0009358 PubMedCrossRefPubMedCentral

35.

Branescu C, Serban D, Dascalu AM, Oprescu SM, Savlovschi C (2013) Interleukin 6 and lipopolysaccharide binding protein—markers of inflammation in acute appendicitis. Chirurgia 108:206–214PubMed

36.

Pavare J, Grope I, Kalnins I, Gardovska D (2010) High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: a prospective study. BMC Infect Dis 10:28. doi:10.1186/1471-2334-10-28 PubMedCrossRefPubMedCentral

37.

Tsalkidou EA, Roilides E, Gardikis S, Trypsianis G, Kortsaris A, Chatzimichael A, Tentes I (2013) Lipopolysaccharide-binding protein: a potential marker of febrile urinary tract infection in childhood. Pediatr Nephrol 28:1091–1097. doi:10.1007/s00467-013-2432-9 PubMedCrossRef

Title: Lipopolysaccharide-binding protein: A valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?
Authors: Max J. Friedrich
Thomas M. Randau
Matthias D. Wimmer
Ben Reichert
Dominik Kuberra
Birgit Stoffel-Wagner
Dieter C. Wirtz
Sascha Gravius
Publication date: 01-10-2014
Publisher: Springer Berlin Heidelberg
Published in: International Orthopaedics / Issue 10/2014
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-014-2351-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lipopolysaccharide-binding protein: A valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?

Abstract

Purpose

Methods

Results

Discussion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 10/2014

Third-generation minimally invasive correction of hallux valgus: technique and early outcomes

Smartphone versus knee ligament arthrometer when size does not matter

Soft tissue coverage of war extremity injuries: the use of pedicle flap transfers in a combat support hospital

Results and complications of single-stage total knee arthroplasty and high tibial osteotomy

Comment on Chang et al.: The safety and efficacy of minimally invasive discectomy: a meta-analysis of prospective randomised controlled trials

Interprosthetic femoral fractures treated with locking plate